Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

i4i Challenge 13 Stage 1 Minutes

Published

12 April 2022

Version

1.0 - April 2022

Contents

Minutes of the Invention for Innovation (i4i) Programme Sub-Committee Meeting to discuss applications to Challenge 13 stage 1.

Date and Location 

Meeting held on Wednesday 9 March 2022 Via Zoom Virtual Meeting. 

In attendance 

Sub-Committee

Professor Nick Lemoine ( Chair)
Ms Jo Smart ( Deputy Chair)

NIHR i4i Secretariat

Mr Mike Lewis( Programme Director)
Dr Ruth Nebauer
Mr Edwin Tucker
Ms Ami Hodges
Dr Ian Newington
Rebecca Stevens
Dr Xi Ye
Dr Francesca Troiani
Dr Michelle Edye

Observers 

Grace O'Toole

The following Stage 1 applications were discussed by the Sub-Committee and invited to progress to Stage 2 or rejected

NIHR204219: TRICORDER: Point-of-Care Cardiovascular Disease Screening With Artificial Intelligence Enabled Stethoscope
Outcome: Invite to Stage 2

NIHR204220: Real World Evaluation of Lifelight®: A contactless vital signs monitor for self monitoring blood pressure
Outcome: Invite to Stage 2 

NIHR204224: Smart fitting solution for lower limb amputees: a real word feasibility study across NHS centres
Outcome: Invite to Stage 2 

NIHR204223: CirrhoCare: A real-world, randomised controlled study, to determine the clinical and cost effectiveness of CirrhoCare digital home monitoring and management in patients with decompensated cirrhosis
Outcome: Invite to Stage 2 

NIHR204225: A pilot programme to evaluate the real-world clinical use of PredictSURE IBD, a prognostic test that predicts severity of future disease course for patients diagnosed with Crohn’s disease and ulcerative colitis. The study will evaluate the impact of implementation of the test and treatment guidance information within existing care pathways, including treatment paradigms & resultant changes in costs, to support discussions with commissioners about reimbursement of PredictSURE IBD following National Institute for Health and Care Excellence (NICE) approval. The pilot will further explore the physicians’ and patients’ understanding of the test and resultant guidance and assess their view on its impact on patient understanding, outcomes and quality of life.
Outcome: Invite to Stage 2

NIHR204213: Study to assess the transferability and scalability of novel surveillance/monitoring/patient-initiated follow-up (PIFU)/ personalised stratified follow-up (PSFU) software technology from Rheumatology to Gastroenterology, Neurology and Breast Cancer.
Outcome: Reject

NIHR204215: A randomised controlled trial to test a digital self-management support intervention for people with type 2 diabetes starting insulin
Outcome: Reject

NIHR204216: Digital Tomosynthesis for imaging wrist injuries: Diagnostic accuracy, patient and user acceptability and cost-effectiveness. The TREIW study.
Outcome: Reject

NIHR204218: Lateral Flow Test Verifier
Outcome: Reject

NIHR204222: Simple epifluorescence microscope for rapid, highly sensitive, routine detection of protein contamination on surgical instruments in Sterile Service Departments.
Outcome: Reject

NIHR204226: Development of a custom-built headset for diagnosis and therapy of Amblyopia
Outcome: Reject

NIHR204227: Implementing a self-management digital health intervention into musculoskeletal clinical pathways: a realist evaluation of clinical and cost effectiveness
Outcome: Reject